Compass Pathways has reported positive six-month results from its second [...]

Telix Pharmaceuticals has received FDA agreement on the protocol and [...]

Atsena Therapeutics has dosed the first patient in the Phase [...]

AstraZeneca’s Imfinzi (durvalumab) has been recommended by NICE for use [...]

Intellia Therapeutics has reported positive Phase 3 results for lonvoguran [...]

Efzimfotase alfa has shown positive Phase 3 results in children [...]

PolyPid is preparing to submit a New Drug Application for [...]

GSK announced that the European Commission has approved Exdensur (depemokimab) [...]

ViiV Healthcare will present new data from its long-acting and [...]

Compass Pathways has reported that its second pivotal Phase 3 [...]